Related Experiment Video
Updated: Mar 17, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
Stereotactic Ablative Radiation Therapy Combined With Immunotherapy for Solid Tumors.
Eric D Brooks1, Jonathan E Schoenhals, Chad Tang
1From the *Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Departments of †Experimental Radiation Oncology and ‡Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX; and Departments of §Dermatology and ∥Pathology, Yale University School of Medicine, New Haven, CT.
Combining immunotherapy with radiation therapy can improve cancer treatment outcomes. This approach enhances the effectiveness of both treatments, potentially transforming radiation into a powerful systemic therapy and overcoming treatment resistance.
Area of Science:
- Oncology
- Radiation Oncology
- Immunology
Background:
- Immunotherapy, specifically immune-checkpoint inhibitors, shows promise in cancer treatment but faces limitations like non-response and relapse.
- There is a need for strategies to enhance the efficacy of immune-checkpoint therapy.
Purpose of the Study:
- To review the synergistic effects of combining radiation therapy with immune-checkpoint inhibitors.
- To explore how stereotactic ablative radiation therapy can potentiate immune-checkpoint therapy.
- To discuss the potential of immunotherapy to enhance radiation therapy's systemic effects.
Main Methods:
- Review of preclinical and clinical studies on combined immunotherapy and radiation.
- Analysis of stereotactic ablative radiation therapy's role in potentiating immune-checkpoint therapy.
Main Results:
- Combination therapy amplifies systemic effects of immunotherapy and immunogenic effects of radiation.
- Stereotactic ablative radiation therapy can enhance immune-checkpoint therapy effectiveness.
- Immunotherapy may enable radiation to act as a systemic treatment.
Conclusions:
- Combining radiation therapy with immune-checkpoint inhibitors offers a promising strategy to improve cancer treatment.
- This combination has the potential to overcome resistance and enhance treatment efficacy.
- Radiation may be repurposed as a systemic therapy when combined with novel immunotherapeutics.
Related Concept Videos
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers

